Advanced BioPhotonics Appoints Vice President of Operations.BOHEMIA, N.Y. -- Advanced BioPhotonics Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : ABPH ABPH American Board of Psychological Hypnosis (Beverly, MA) ABPH Associated British Ports Holdings PLC (UK) ABPH Able Seaman Photographer ), a leading developer of medical-imaging applications announced today the hiring of David Wright as Vice President of Operations. Mr. Wright will be responsible for overseeing the production, procurement, quality and technical support operations of the Company. "I have had the pleasure of working with David in the past," said Denis Denis, king of Portugal: see Diniz. O'Connor, Chief Executive Officer of Advanced BioPhotonics. "He is a seasoned professional with a diverse set of talents that greatly enhances our executive team." Mr. Wright brings two decades of experience in the medical imaging field to his new role at Advanced BioPhotonics. Prior to Advanced BioPhotonics Inc., since March 2004, he had been Director of Service for DOBI DOBI Division of Banking and Insurance Medical International, Inc., a publicly traded company publicly traded company A company whose shares of common stock are held by the public and are available for purchase by investors. The shares of publicly traded firms are bought and sold on the organized exchanges or in the over-the-counter market. specializing in breast imaging technology. From 2002 to 2004 he served various roles at Swissray America including Director of Service, Director of IT and Director of Technical Operations. Previously, over the last 20 years, Mr. Wright has held positions in medical imaging operations with such companies as Toshiba Medical Systems and Fonar Corporation. "The BioScanIR(R) System is an innovative and exciting imaging technology that offers the potential to improve the quality of patient care and outcomes," said David Wright. "I look forward to working with the team at Advanced BioPhotonics." About Advanced BioPhotonics Advanced BioPhotonics Inc. (OTCBB: ABPH) headquartered in Bohemia, New York Bohemia is a hamlet (and census-designated place) in Suffolk County, New York, United States. The population was 9,871 at the 2000 census. Bohemia is in the Town of Islip. , is an innovative developer of medical imaging applications using advanced infrared technology. Advanced BioPhotonics provides imaging technology for clinicians and researchers for use in the detection and management of diseases affecting perfusion or reperfusion re·per·fu·sion n. The restoration of blood flow to an organ or tissue that has had its blood supply cut off, as after a heart attack. of tissue or organs. Advanced BioPhotonics's mission is to improve the quality and cost-effectiveness of healthcare services and research through identifying, acquiring and adapting high-resolution infrared technology for biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. applications. For more information about the Company and its technology, please visit http://www.advancedbp.com/. This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, the ability of the Company to develop effective new products and receive governmental approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion